Biotage AB (STU:PQX1) Long-Term Capital Lease Obligation : €6.5 Mil (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Biotage AB Long-Term Capital Lease Obligation?

Biotage AB's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €6.5 Mil.

Biotage AB's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (€6.0 Mil) to Dec. 2023 (€6.8 Mil) but then declined from Dec. 2023 (€6.8 Mil) to Mar. 2024 (€6.5 Mil).

Biotage AB's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (€2.9 Mil) to Dec. 2022 (€3.8 Mil) and increased from Dec. 2022 (€3.8 Mil) to Dec. 2023 (€6.8 Mil).

Biotage AB Long-Term Capital Lease Obligation Historical Data

The historical data trend for Biotage AB's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Long-Term Capital Lease Obligation Chart

Biotage AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

3.64

3.05

2.92

3.82

6.79

Biotage AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															4.10	3.94	6.00	6.79	6.54

Biotage AB (STU:PQX1) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Biotage AB Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Biotage AB's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotage AB (STU:PQX1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (STU:PQX1) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

BIOT:Sweden 0GRP:UK

Address

Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03

Website

https://www.biotage.com

Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (STU:PQX1) Headlines

No Headlines